Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

JAMA 2022;327(2):138–50 doi:10.1001/jama.2021.23619

In this publication, Rubino et al discuss the results of the STEP 8 trial, which directly compared semaglutide and liraglutide for weight management in adults with overweight or obesity, with or without T2D.


LinkedIn